Ad
related to: united states coronavirus update
Search results
Realty Income: Buy, Sell, or Hold?
The Motley Fool via AOL· 6 days ago* Stock Advisor provides investors with an easy-to-follow blueprint for success, including guidance on building a portfolio, regular updates from...
STEVE CORBIN: Project 2025's threat to democracy
Waterloo-Cedar Falls Courier· 4 days agoProject 2025 is a playbook specifically created for Donald Trump and his minions to use in the first 180 days of a Trump presidential administration if...
DC attorney general reaches $40m tax case settlement with founder of MicroStrategy - The Boston...
The Boston Globe· 2 days agoAmerican Airlines pushed a federal appeals court to overturn a decision invalidating its partnership...
Theralase(R) Technology Effective in Virus Inactivation
Morningstar· 1 day agoTORONTO, ON / ACCESSWIRE / June 4, 2024 / Theralase® Technologies Inc. ("Theralase®" or the "Company") (TSXV:TLT)(OTCQB:TLTFF), a clinical stage pharmaceutical company dedicated to the research ...
The Sustained, Slow Declining, Blood Concentration Profile of NV-387 Enables Infrequent Dosing for...
Morningstar· 1 day agoThe Company has found that its lead nanoviricide broad-spectrum antiviral drug candidate NV-387, when given as a slow bolus intravenous infusion, resulted in a relatively flat plateau of blood ...
Stanford study suggests new ways of predicting, treating breast cancer through genes
Newsday· 6 days agoA new study has found that the genes people are born with — and how they interact with the immune...
AP News Summary at 6:33 a.m. EDT
The Longview News-Journal· 8 hours agoThe Lebanese army said Wednesday that at least one gunman attempted to attack on the U.S. Embassy near Beirut. The Lebanese military in a statement said that soldiers shot an assailant, who ...
Theralase(R) Technology Effective in Virus Inactivation
The Joplin Globe· 1 day agoTORONTO, ON / ACCESSWIRE / June 4, 2024 / Theralase® Technologies Inc. ("Theralase®" or the "Company") (TSXV:TLT)(OTCQB:TLTFF), a clinical stage pharmaceutical company dedicated to the research ...
Takeda Receives Positive CHMP Opinion for Recombinant ADAMTS13 (rADAMTS13) in Congenital Thrombotic...
Benzinga· 5 days agoTakeda ((TAK) today announced that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended the approval, under exceptional circumstances, ...
Small Business - Shelby County Reporter | Shelby County Reporter
The Shelby County Reporter· 4 days agoTaseko Mines Limited (TSX: TKO) (NYSE MKT: TGB) (LSE: TKO) ("Taseko" or the "Company") announced today that operations at the Company's Gibraltar Mine have been suspended. Collective bargaining ...
